BioLineRx Competitors and Similar CompaniesClear all
BioLineRx's competitors and similar companies include Epizyme, Janssen, Loxo Oncology and Ascentage Pharma.
 Epizyme Epizyme is a clinical stage biopharmaceutical company focusing on treatments for blood cancer and tumors. |  Loxo Oncology Loxo Oncology is a biopharmaceutical company focused on targeted cancer therapies for genetically-defined patient populations. |  Ascentage Pharma Ascentage Pharma Group International (亚盛闘棄集團) is a biopharmaceutical company that is engaged in discovering, developing, and commercializing therapies. | |||
Founding Date | Founding Date 2003 | Founding Date 2007 | Founding Date 1953 | Founding Date 2013 | Founding Date 2017 |
Type | Type Public | Type Public | Type Subsidiary | Type Subsidiary | Type Public |
Tags | |||||
Locations | Locations Modi'in-Maccabim-Re'ut, IL HQ | Locations Cambridge, US HQ | Locations Stamford, US HQ Alcobendas, ES Boulder, US New York, US South San Francisco, US | Locations Suzhou, CN HQ Guangzhou Shi, CN Suzhou Shi, CN Taizhou, CN Rockville, US | |
Employees | Employees 2414% decrease | Employees 20364% increase | Employees 17,3684% decrease | Employees 65610% decrease | Employees 567 |
Valuation ($) | Valuation ($) 38.5 m | Valuation ($) 250.8 m | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) N/A |
Financial | |||||
Revenue (est.) | Revenue (est.) $1.2m (FY, 2025) | Revenue (est.) $37.4m (FY, 2021) | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) ¥574.1m (FY, 2025) |
Cost of goods | Cost of goods $230k (FY, 2025) | Cost of goods $10.5m (FY, 2021) | Cost of goods N/A | Cost of goods N/A | Cost of goods ¥48.9m (FY, 2025) |
Gross profit | Gross profit $950k (FY, 2025) | Gross profit N/A | Gross profit N/A | Gross profit N/A | Gross profit ¥546.6m (FY, 2025) |
Net income | Net income ($2m) (FY, 2025) | Net income ($251.1m) (FY, 2021) | Net income N/A | Net income ($148.9m) (FY, 2017) | Net income (¥1.2b) (FY, 2025) |
Funding | |||||
Total funding raised | Total funding raised $ 100.9m | Total funding raised $ 51.5m | Total funding raised N/A | Total funding raised $ 57m | Total funding raised $ 237.5m |
For sources of this data, please see the company profile
View Company Profiles
Epizyme
HQ
Cambridge, US
Employees
203
Epizyme is a clinical stage biopharmaceutical company focusing on treatments for blood cancer and tumors.
View company
Janssen
HQ
Raritan, US
Janssen is a company providing prescription pharmaceutical products.
View companyLoxo Oncology
HQ
Stamford, US
Loxo Oncology is a biopharmaceutical company focused on targeted cancer therapies for genetically-defined patient populations.
View companyAscentage Pharma
HQ
Suzhou, CN
Employees
567
Ascentage Pharma Group International (亚盛闘棄集團) is a biopharmaceutical company that is engaged in discovering, developing, and commercializing therapies.
View company